Latest Articles
BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer TipRanks
Published: Aug. 22, 2025, 4:17 p.m.
BioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer TipRanks
Published: Aug. 20, 2025, 4:07 p.m.
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers - TipRanks
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers TipRanks
Published: Aug. 20, 2025, 4:06 p.m.
Prime Minister shares an article highlighting the government’s landmark initiatives, such as the National Critical Minerals Mission, Mission Sudarshan Chakra, Viksit Bharat Rozgar Yojana, National Deep Water Exploration - India Education Diary
Prime Minister shares an article highlighting the government’s landmark initiatives, such as the National Critical Minerals Mission, Mission Sudarshan Chakra, Viksit Bharat Rozgar Yojana, National Deep Water Exploration India Education …
Published: Aug. 19, 2025, 8:17 a.m.
Endometriosis: Myths and Misconceptions - Cedars-Sinai
Endometriosis: Myths and Misconceptions Cedars-Sinai
Published: Aug. 18, 2025, 12:50 p.m.
Bindi Irwin Misses Annual Steve Irwin Gala Due to Unexpected Medical Emergency: 'Health Has to Come First,' Brother Robert Says - MSN
Bindi Irwin Misses Annual Steve Irwin Gala Due to Unexpected Medical Emergency: 'Health Has to Come First,' Brother Robert Says MSN
Published: Aug. 16, 2025, 10:58 p.m.
Dr. Sara Szal Breaks Down The Most Misdiagnosed Hormone Problems On ‘Treated’ - Dear Media
Dr. Sara Szal Breaks Down The Most Misdiagnosed Hormone Problems On ‘Treated’ Dear Media
Published: Aug. 16, 2025, 9:28 a.m.
Mismatch Repair Status Predicts Endometrial Cancer Outcomes - Medscape
Mismatch Repair Status Predicts Endometrial Cancer Outcomes Medscape
Published: Aug. 11, 2025, noon
Mismatch Repair Status Linked to Endometrial Cancer Outcomes, Real-World Study Reveals - Medscape
Mismatch Repair Status Linked to Endometrial Cancer Outcomes, Real-World Study Reveals Medscape
Published: Aug. 11, 2025, noon
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials - Stock Titan
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials Stock Titan
Published: Aug. 6, 2025, 1 p.m.
Link copied to clipboard!